111 related articles for article (PubMed ID: 9737965)
1. Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.
Parman T; Chen G; Wells PG
J Biol Chem; 1998 Sep; 273(39):25079-88. PubMed ID: 9737965
[TBL] [Abstract][Full Text] [Related]
2. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
Liu L; Wells PG
Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
[TBL] [Abstract][Full Text] [Related]
3. Oxidative damage in chemical teratogenesis.
Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
[TBL] [Abstract][Full Text] [Related]
4. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis.
Winn LM; Wells PG
Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124
[TBL] [Abstract][Full Text] [Related]
5. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
Kubow S; Wells PG
Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin H synthase-catalyzed oxidation of all-trans- and 13-cis-retinoic acid to carbon-centered and peroxyl radical intermediates.
Freyaldenhoven MA; Lloyd RV; Samokyszyn VM
Chem Res Toxicol; 1996 Jun; 9(4):677-81. PubMed ID: 8831809
[TBL] [Abstract][Full Text] [Related]
7. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S
Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration.
Jeng W; Ramkissoon A; Parman T; Wells PG
FASEB J; 2006 Apr; 20(6):638-50. PubMed ID: 16581972
[TBL] [Abstract][Full Text] [Related]
10. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
Liu L; Wells PG
Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
Kim PM; Wells PG
Mol Pharmacol; 1996 Jan; 49(1):172-81. PubMed ID: 8569704
[TBL] [Abstract][Full Text] [Related]
12. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
Parman T; Wiley MJ; Wells PG
Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
[TBL] [Abstract][Full Text] [Related]
13. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
Yu WK; Wells PG
Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
[TBL] [Abstract][Full Text] [Related]
14. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
Lee CJ; Gonçalves LL; Wells PG
FASEB J; 2011 Jul; 25(7):2468-83. PubMed ID: 21502285
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies.
Gonçalves LL; Ramkissoon A; Wells PG
Chem Res Toxicol; 2009 May; 22(5):842-52. PubMed ID: 19374330
[TBL] [Abstract][Full Text] [Related]
16. Identification of 3-MI-derived N-centered radicals obtained from incubation of 3-MI with microsomal-NADPH system by EPR-HPLC spin trapping.
Chen G; Janzen EG; Bray TM
Free Radic Biol Med; 1994 Jul; 17(1):19-25. PubMed ID: 7959163
[TBL] [Abstract][Full Text] [Related]
17. The oxidation of arachidonic acid by the cyclooxygenase activity of purified prostaglandin H synthase: spin trapping of a carbon-centered free radical intermediate.
Schreiber J; Eling TE; Mason RP
Arch Biochem Biophys; 1986 Aug; 249(1):126-36. PubMed ID: 3017218
[TBL] [Abstract][Full Text] [Related]
18. A carbon-centered free radical intermediate in the prostaglandin synthetase oxidation of arachidonic acid. Spin trapping and oxygen uptake studies.
Mason RP; Kalyanaraman B; Tainer BE; Eling TE
J Biol Chem; 1980 Jun; 255(11):5019-22. PubMed ID: 6246094
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine.
Boyd JA; Eling TE
Cancer Res; 1987 Aug; 47(15):4007-14. PubMed ID: 3111680
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase.
Hughes MF; Mason RP; Eling TE
Mol Pharmacol; 1988 Aug; 34(2):186-93. PubMed ID: 2842654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
